As reported, cisplatin binds to IRP2 and mediates inactivation of IRP2, which causes the downregulation of TfR1 and the upregulation of ferritin, leading to sustained intracellular iron deficiency and suppression of cancer cells growth [64]. Here, IREB2 is linked to cancer.